Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pediatric Multiple Sclerosis”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Not applicableStudy completedNCT03942952
What this trial is testing

PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes.

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingNeuromyelitis OpticaAcute Disseminated Encephalomyelitis+1 more
University of Texas Southwestern Medical Center 49
Not applicableNot Yet RecruitingNCT07257900
What this trial is testing

Comparison of Structured Exercise and Exergaming in Pediatric-Onset Multiple Sclerosis

Who this might be right for
Pediatric-Onset Multiple Sclerosis (POMS)Exercise Training
Istanbul University - Cerrahpasa 30
Not applicableStudy completedNCT04660227
What this trial is testing

Exercise Training in Pediatric-Onset Multiple Sclerosis Patients

Who this might be right for
Pediatric Multiple Sclerosis
Istanbul University - Cerrahpasa 20
Not applicableUnknownNCT03087136
What this trial is testing

Observational Study to Evaluate Pediatric Multiple Sclerosis in Brazil

Who this might be right for
Multiple Sclerosis
Pontificia Universidade Católica do Rio Grande do Sul 100
Early research (Phase 1)UnknownNCT02200718
What this trial is testing

NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Immune Response BioPharma, Inc. 12
Large-scale testing (Phase 3)Study completedNCT02283853
What this trial is testing

Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Subjects With Relapsing-remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 156
Not applicableStudy completedNCT01396343
What this trial is testing

Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis

Who this might be right for
Pediatric Multiple Sclerosis
University of California, San Francisco 1,276
Testing effectiveness (Phase 2)Study completedNCT03650452
What this trial is testing

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies

Who this might be right for
EpilepsyDravet SyndromeLennox-Gastaut Syndrome
Takeda 141
Testing effectiveness (Phase 2)Ended earlyNCT05000216
What this trial is testing

COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders

Who this might be right for
Rheumatoid Arthritis (RA)Systemic Lupus Erythematosus (SLE)Pemphigus Vulgaris+6 more
National Institute of Allergy and Infectious Diseases (NIAID) 258
Not applicableLooking for participantsNCT05469373
What this trial is testing

ESIS in Pediatric DRE

Who this might be right for
Epilepsy
Sarah Katie Ihnen 86
Not applicableUnknownNCT02361697
What this trial is testing

DTI in Children With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis - Relapsing RemittingClinically Isolated Syndrome, CNS Demyelinating
University Hospital Muenster 15
Not applicableStudy completedNCT02234713
What this trial is testing

Adherence in Pediatric Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
The Hospital for Sick Children 71
Post-approval studies (Phase 4)Study completedNCT04667949
What this trial is testing

Study of Efficacy and Safety of Fingolimod (Gilenya) 0.5 mg in Chinese Patients With Relapsing Multiple Sclerosis (RMS) Patients

Who this might be right for
Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals 98
Not applicableStudy completedNCT01207648
What this trial is testing

Retrospective Cohort Study of Rebif® Use in Pediatric Multiple Sclerosis (MS) Subjects (REPLAY)

Who this might be right for
Multiple Sclerosis
EMD Serono 307
Not applicableUnknownNCT05123924
What this trial is testing

Respiratory Functions in Pediatric-Onset Multiple Sclerosis

Who this might be right for
Pediatric-onset Multiple Sclerosis
Istanbul University - Cerrahpasa 46
Testing effectiveness (Phase 2)Study completedNCT02410200
What this trial is testing

Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 22
Large-scale testing (Phase 3)Ended earlyNCT03368664
What this trial is testing

Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT

Who this might be right for
Multiple Sclerosis
Genzyme, a Sanofi Company 16
Large-scale testing (Phase 3)Ended earlyNCT03870763
What this trial is testing

Study to Evaluate the Efficacy and Safety of Dimethyl Fumarate (Tecfidera) and Peginterferon Beta-1a (Plegridy) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Pediatric Participants

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 11
Not applicableStudy completedNCT02137109
What this trial is testing

Safety and Efficacy in Pediatric MS Patients Prescribed Tysabri

Who this might be right for
Multiple Sclerosis
Biogen 400
Early research (Phase 1)Study completedNCT01884935
What this trial is testing

PK and PD Study of Natalizumab in Pediatric Subjects With RRMS

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 13
Load More Results